Current Understanding and Treatment of Cardiac and Skeletal Muscle Pathology in Laminin-Α2 Chain-Deficient Congenital Muscular Dystrophy

The Application of Clinical Genetics - New Zealand
doi 10.2147/tacg.s187481
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Informa UK Limited

Related search

Angiotensin II Type 1 Receptor Antagonists Alleviate Muscle Pathology in the Mouse Model for Laminin-Α2-Deficient Congenital Muscular Dystrophy (MDC1A)

Skeletal Muscle
OrthopedicsSports MedicineCell BiologyMolecular Biology
2012English

Amelioration of Laminin- 2-Deficient Congenital Muscular Dystrophy by Somatic Gene Transfer of Miniagrin

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Congenital Muscular Dystrophy: From Muscle to Brain

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2016English

294. Restriction of Calpain3 Expression to the Skeletal Muscle Prevents Cardiac Toxicity and Corrects Pathology in a Murine Model of Limb-Girdle Muscular Dystrophy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Congenital Muscular Dystrophy

The Internet Journal of Radiology
2010English

Identification and Function of Fibrocytes in Skeletal Muscle Injury Repair and Muscular Dystrophy

Journal of Immunology
AllergyImmunology
2016English

Congenital Muscular Dystrophy and .ALPHA.-dystroglycanopathy

Clinical Neurology
Neurology
2008English

Mitigation of Muscular Dystrophy in Mice by SERCA Overexpression in Skeletal Muscle

Journal of Clinical Investigation
Medicine
2011English

Use of Skeletal Muscle MRI in Diagnosis and Monitoring Disease Progression in Duchenne Muscular Dystrophy

Physical Medicine and Rehabilitation Clinics of North America
Physical TherapySports TherapyRehabilitation
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy